ChromoGenics AB

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

ChromoGenics AB - overview

Established

2003

Location

Uppsala, -, Sweden

Primary Industry

Chemicals

About

ChromoGenics AB develops innovative electrochromic glazing products, enhancing energy efficiency through adjustable solar control solutions that significantly reduce energy consumption in buildings. Founded in 2003 in Uppsala, Sweden, ChromoGenics AB specializes in electrochromic technology for dynamic glass solutions designed to control sunlight and heat entry. The company has engaged in 10 deals, with its most recent funding round being a Grant of EUR 7. 4 million from the Swedish Energy Agency in December 2012, totaling EUR 31.


0 mn raised. The current CEO is Thomas Almesjö. ChromoGenics AB specializes in the development and commercialization of electrochromic glazing products under the brand ConverLight®. Their core offering is a dynamic glass solution that allows for adjustable solar control, enhancing indoor comfort while significantly reducing energy consumption.


This technology operates through electrochromic materials that change tint in response to voltage, allowing users to manage the amount of sunlight and heat entering a building. Key applications include commercial and residential buildings where energy efficiency, climate control, and sustainability are paramount. ChromoGenics serves a diverse client base that includes architects, builders, and property developers, particularly in the European, North American, and Asian markets, where there is a growing demand for energy-efficient building solutions. ChromoGenics generated revenue of EUR 1,811,259.


10 in 2022, with an EBITDA of EUR -5,213,073. 60. Their revenue structure relies on direct sales of electrochromic glazing solutions and partnerships with construction firms and architectural designers, primarily through B2B transactions for large-scale installations or retrofitting existing structures. The flagship product, ConverLight®, is vital for driving sales and partnerships in both commercial and residential projects.


ChromoGenics plans to leverage the recent Grant financing of EUR 7. 4 million to support product development and market expansion. The company aims to introduce new products that enhance the functionality of their electrochromic glazing solutions. Additionally, ChromoGenics targets expansion into markets across Europe, North America, and Asia by the end of 2024, capitalizing on the rising demand for energy-efficient building solutions.


Current Investors

Industrifonden, Volvo Group Venture Capital, NES Partners

Primary Industry

Chemicals

Sub Industries

Power Generation Equipment & Services, Chemicals

Website

www.chromogenics.com

Company Stage

Series B

Total Amount Raised

Subscriber access only

ChromoGenics AB - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

ChromoGenics AB - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

ChromoGenics AB - key contacts

NamePositionStart DateEnd DateVcardBio 
Member Board Of DirectorsBM
Member of the BoardBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.